SCHEMBL3897268

SCHEMBL3897268

COC(=O)C1=C(Nc2ccc(C(=O)N(C)C)cc2)CC(C(=O)OC)=C(Nc2ccc(C(=O)N(C)C)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CSNK2A1 P68400 3/20 0.42
▸ POLB P06746 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ FTO Q9C0B1 1/20 0.39
▸ EGLN1 Q9GZT9 1/20 0.39
▸ HIF1AN Q9NWT6 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ USP2 O75604 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ LCK P06239 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3902803 0.82 MAPT (0.45) HPGDALDH1A1SMN1; SMN2HSD17B10MEN1
SCHEMBL1415828 0.80 TDP1 (0.48) HPGDALDH1A1SMN1; SMN2POLBCYP1A2
SCHEMBL1415795 0.78 ACHE (0.44) HPGDALDH1A1MEN1KMT2AKDM4E
SCHEMBL1415465 0.78 MEN1 (0.49) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL1415617 0.78 SLC6A3 (0.49) HPGDALDH1A1POLBUSP2MEN1
SCHEMBL1415808 0.78 HTT (0.54) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL3909905 0.78 MAPT (0.53) HPGDALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL3897271 0.76 JAK3 (0.36) HPGDALDH1A1SMN1; SMN2CSNK2A1POLB
SCHEMBL3905197 0.76 SLC6A3 (0.52) HPGDSMN1; SMN2CYP3A4MEN1KMT2A
SCHEMBL457540 0.75 ALDH1A1 (0.61) HPGDALDH1A1SMN1; SMN2HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0632106-B2 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MFG CO (JP) 2009-02-25 — — EP disclosed
EP-0632106-B1 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MFG CO (JP) 2001-08-22 — — EP disclosed
US-5817817-A Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1998-10-06 — — US disclosed
US-5659036-A Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1997-08-19 — — US disclosed
EP-0632106-A1 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1995-01-04 — — EP disclosed
Send feedback